Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Neurovascular Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Neurovascular Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-03-19

Pages: 79 Pages

Report ld: 3834561

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Neurovascular Devices Market Size(US$)

CAGR 2025-2031

5.3%

Market Size,2031

USD 4,384

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 3,216 million

Market Forecast in 2031(Value)

US$ 4,384 million

CAGR

5.3%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Neurovascular Devices market size was US$ 3195 million in 2024 and is forecast to a readjusted size of US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.

Neurovascular devices are medical devices used to diagnose, treat, and manage various diseases affecting the blood vessels in the brain and nervous system. Neurovascular diseases typically include conditions such as stroke (both ischemic and hemorrhagic), brain aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities. These devices play a critical role in neurovascular procedures, enabling minimally invasive treatments that enhance patient outcomes.

Common neurovascular devices include stents, coils, embolization devices, flow diversion devices, microcatheters, aspiration systems, and intracranial pressure (ICP) monitors. Stents are primarily used to treat narrowed blood vessels, often in patients with cerebral aneurysms or carotid artery disease. Coils are used to embolize brain aneurysms, promoting clot formation inside the aneurysm and reducing the risk of rupture. Flow diversion devices are used to alter blood flow in the brain, typically for aneurysm treatment, to reduce the risk of rupture. Microcatheters and embolization devices are mainly used to occlude abnormal blood vessels in conditions like AVMs or tumors. Aspiration devices are employed to remove blood clots in acute ischemic strokes, restoring blood flow to the brain.

These devices have significantly advanced the treatment of neurovascular diseases, improving the precision and safety of procedures. As medical technology progresses, the role of these devices in minimally invasive surgeries continues to grow, and they will remain essential in the development of the field of neurointervention and neurosurgery.

1. Market Development Opportunities and Key Drivers:

The market for neurovascular devices is driven by several key factors:

Rising Stroke Incidence: As the global population ages, the incidence of strokes, especially ischemic strokes, continues to increase, driving demand for neurovascular devices.

Technological Advancements: With the development of minimally invasive technologies, neurovascular procedures have become more precise and safer. New devices and materials, such as flow diversion devices and automated aspiration systems, have made neurointerventional procedures more efficient and feasible.

Expanded Healthcare Coverage: The expansion of healthcare insurance systems and increasing healthcare expenditures have driven the demand for effective medical devices.

Increased Health Awareness: As public awareness of cerebrovascular diseases rises, there is a growing demand for early diagnosis and prevention, further fueling the neurovascular device market.

2. Market Risks:

High Treatment Costs: Neurovascular devices are often expensive, particularly high-end devices and treatments, which may create entry barriers in developing countries.

Technological Risks: The development of new technologies is uncertain, requiring long clinical trials and regulatory approvals. Additionally, the rapid pace of technological advancements may render products obsolete.

Regulatory and Compliance Risks: The approval process for medical devices is stringent, especially for new technologies, and regulatory challenges may hinder market adoption.

3. Market Concentration:

The neurovascular device market is relatively concentrated, with a few leading global medical device companies dominating the market. Major players include Medtronic, Stryker, Boston Scientific, and others. These companies have strong R&D capabilities and extensive distribution networks, enabling them to provide high-quality products and maintain a dominant position globally.

4. Downstream Demand Trends:

Increasing Demand Due to Aging Population: As the global population ages, the prevalence of cerebrovascular diseases such as strokes continues to rise, driving the demand for neurovascular treatments and devices.

Preference for Minimally Invasive Procedures: Patients increasingly prefer minimally invasive surgeries, which reduce hospital stays and recovery times, leading to a growing demand for minimally invasive neurovascular devices.

Customized Treatment Needs: With the advancement of precision medicine, there is an increasing demand for personalized treatment solutions, which has led to the development of tailored neurovascular devices.

5. Latest Technologies:

Flow Diversion Devices: This technology has made significant progress in treating brain aneurysms, especially in high-risk patients, by diverting blood flow away from the aneurysm to reduce the risk of rupture.

Automated Aspiration Systems: These systems are used for clot retrieval in acute ischemic stroke, enabling rapid and effective restoration of blood flow to the brain.

Minimally Invasive Surgical Systems: Recent advancements in minimally invasive surgery have made neurovascular procedures more precise, reducing surgical risks and recovery times by using smaller catheters and more accurate techniques.

The global Neurovascular Devices market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Stryker Corporation
Johnson & Johnson
Medtronic
Terumo Neuro
Penumbra, Inc. (Neuro)
Shanghai MicroPort Medical (Group) Co.，Ltd.
Abbott Vascular
Medical Murray
Boston Scientific

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Thrombectomy Devices
Intracranial Stents
Embolization Devices
Flow Diversion Devices
Others

Segment by Application

Stroke Treatment
Aneurysm Treatment
Cerebral Vascular Stenosis Treatment
Traumatic Brain Injury and Intracranial Hemorrhage Treatment
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Neurovascular Devices market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Intracranial Stents in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Aneurysm Treatment in India).

Chapter 6: Regional revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Neurovascular Devices value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Thrombectomy Devices

1.2.3 Intracranial Stents

1.2.4 Embolization Devices

1.2.5 Flow Diversion Devices

1.2.6 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Stroke Treatment

1.3.3 Aneurysm Treatment

1.3.4 Cerebral Vascular Stenosis Treatment

1.3.5 Traumatic Brain Injury and Intracranial Hemorrhage Treatment

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neurovascular Devices Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Neurovascular Devices Revenue Market Share by Region (2020-2025)

2.4 Global Neurovascular Devices Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Neurovascular Devices Market Size and Prospective (2020-2031)

2.5.2 Europe Neurovascular Devices Market Size and Prospective (2020-2031)

2.5.3 China Neurovascular Devices Market Size and Prospective (2020-2031)

2.5.4 Japan Neurovascular Devices Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Neurovascular Devices Historic Market Size by Type (2020-2025)

3.2 Global Neurovascular Devices Forecasted Market Size by Type (2026-2031)

3.3 Different Types Neurovascular Devices Representative Players

4 Breakdown Data by Application

4.1 Global Neurovascular Devices Historic Market Size by Application (2020-2025)

4.2 Global Neurovascular Devices Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Neurovascular Devices Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Neurovascular Devices Players by Revenue (2020-2025)

5.1.2 Global Neurovascular Devices Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Neurovascular Devices Revenue

5.4 Global Neurovascular Devices Market Concentration Analysis

5.4.1 Global Neurovascular Devices Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Neurovascular Devices Revenue in 2024

5.5 Global Key Players of Neurovascular Devices Head office and Area Served

5.6 Global Key Players of Neurovascular Devices, Product and Application

5.7 Global Key Players of Neurovascular Devices, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Neurovascular Devices Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Neurovascular Devices Market Size by Type (2020-2025)

6.1.2.2 North America Neurovascular Devices Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Neurovascular Devices Market Size by Application (2020-2025)

6.1.3.2 North America Neurovascular Devices Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Neurovascular Devices Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Neurovascular Devices Market Size by Type (2020-2025)

6.2.2.2 Europe Neurovascular Devices Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Neurovascular Devices Market Size by Application (2020-2025)

6.2.3.2 Europe Neurovascular Devices Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Neurovascular Devices Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Neurovascular Devices Market Size by Type (2020-2025)

6.3.2.2 China Neurovascular Devices Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Neurovascular Devices Market Size by Application (2020-2025)

6.3.3.2 China Neurovascular Devices Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Neurovascular Devices Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Neurovascular Devices Market Size by Type (2020-2025)

6.4.2.2 Japan Neurovascular Devices Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Neurovascular Devices Market Size by Application (2020-2025)

6.4.3.2 Japan Neurovascular Devices Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

7 Key Players Profiles

7.1 Stryker Corporation

7.1.1 Stryker Corporation Company Details

7.1.2 Stryker Corporation Business Overview

7.1.3 Stryker Corporation Neurovascular Devices Introduction

7.1.4 Stryker Corporation Revenue in Neurovascular Devices Business (2020-2025)

7.1.5 Stryker Corporation Recent Development

7.2 Johnson & Johnson

7.2.1 Johnson & Johnson Company Details

7.2.2 Johnson & Johnson Business Overview

7.2.3 Johnson & Johnson Neurovascular Devices Introduction

7.2.4 Johnson & Johnson Revenue in Neurovascular Devices Business (2020-2025)

7.2.5 Johnson & Johnson Recent Development

7.3 Medtronic

7.3.1 Medtronic Company Details

7.3.2 Medtronic Business Overview

7.3.3 Medtronic Neurovascular Devices Introduction

7.3.4 Medtronic Revenue in Neurovascular Devices Business (2020-2025)

7.3.5 Medtronic Recent Development

7.4 Terumo Neuro

7.4.1 Terumo Neuro Company Details

7.4.2 Terumo Neuro Business Overview

7.4.3 Terumo Neuro Neurovascular Devices Introduction

7.4.4 Terumo Neuro Revenue in Neurovascular Devices Business (2020-2025)

7.4.5 Terumo Neuro Recent Development

7.5 Penumbra, Inc. (Neuro)

7.5.1 Penumbra, Inc. (Neuro) Company Details

7.5.2 Penumbra, Inc. (Neuro) Business Overview

7.5.3 Penumbra, Inc. (Neuro) Neurovascular Devices Introduction

7.5.4 Penumbra, Inc. (Neuro) Revenue in Neurovascular Devices Business (2020-2025)

7.5.5 Penumbra, Inc. (Neuro) Recent Development

7.6 Shanghai MicroPort Medical (Group) Co.，Ltd.

7.6.1 Shanghai MicroPort Medical (Group) Co.，Ltd. Company Details

7.6.2 Shanghai MicroPort Medical (Group) Co.，Ltd. Business Overview

7.6.3 Shanghai MicroPort Medical (Group) Co.，Ltd. Neurovascular Devices Introduction

7.6.4 Shanghai MicroPort Medical (Group) Co.，Ltd. Revenue in Neurovascular Devices Business (2020-2025)

7.6.5 Shanghai MicroPort Medical (Group) Co.，Ltd. Recent Development

7.7 Abbott Vascular

7.7.1 Abbott Vascular Company Details

7.7.2 Abbott Vascular Business Overview

7.7.3 Abbott Vascular Neurovascular Devices Introduction

7.7.4 Abbott Vascular Revenue in Neurovascular Devices Business (2020-2025)

7.7.5 Abbott Vascular Recent Development

7.8 Medical Murray

7.8.1 Medical Murray Company Details

7.8.2 Medical Murray Business Overview

7.8.3 Medical Murray Neurovascular Devices Introduction

7.8.4 Medical Murray Revenue in Neurovascular Devices Business (2020-2025)

7.8.5 Medical Murray Recent Development

7.9 Boston Scientific

7.9.1 Boston Scientific Company Details

7.9.2 Boston Scientific Business Overview

7.9.3 Boston Scientific Neurovascular Devices Introduction

7.9.4 Boston Scientific Revenue in Neurovascular Devices Business (2020-2025)

7.9.5 Boston Scientific Recent Development

8 Neurovascular Devices Market Dynamics

8.1 Neurovascular Devices Industry Trends

8.2 Neurovascular Devices Market Drivers

8.3 Neurovascular Devices Market Challenges

8.4 Neurovascular Devices Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Neurovascular Devices Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Neurovascular Devices Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Neurovascular Devices Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Neurovascular Devices Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Neurovascular Devices Revenue Share by Region (2020-2025)

Table 6. Global Neurovascular Devices Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Neurovascular Devices Revenue Share Forecast by Region (2026-2031)

Table 8. Global Neurovascular Devices Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Neurovascular Devices Revenue Market Share by Type (2020-2025)

Table 10. Global Neurovascular Devices Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Neurovascular Devices Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Neurovascular Devices Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Neurovascular Devices Revenue Market Share by Application (2020-2025)

Table 15. Global Neurovascular Devices Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Neurovascular Devices Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Neurovascular Devices Application

Table 18. Global Neurovascular Devices Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Neurovascular Devices Market Share by Players (2020-2025)

Table 20. Global Top Neurovascular Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Devices as of 2024)

Table 21. Ranking of Global Top Neurovascular Devices Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Neurovascular Devices Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Neurovascular Devices, Headquarters and Area Served

Table 24. Global Key Players of Neurovascular Devices, Product and Application

Table 25. Global Key Players of Neurovascular Devices, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Neurovascular Devices Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Neurovascular Devices Revenue Market Share by Company (2020-2025)

Table 29. North America Neurovascular Devices Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Neurovascular Devices Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Neurovascular Devices Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Neurovascular Devices Revenue Market Share by Company (2020-2025)

Table 33. Europe Neurovascular Devices Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Neurovascular Devices Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Neurovascular Devices Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Neurovascular Devices Revenue Market Share by Company (2020-2025)

Table 37. China Neurovascular Devices Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Neurovascular Devices Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Neurovascular Devices Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Neurovascular Devices Revenue Market Share by Company (2020-2025)

Table 41. Japan Neurovascular Devices Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Neurovascular Devices Market Size by Application (2020-2025) & (US$ Million)

Table 43. Stryker Corporation Company Details

Table 44. Stryker Corporation Business Overview

Table 45. Stryker Corporation Neurovascular Devices Product

Table 46. Stryker Corporation Revenue in Neurovascular Devices Business (2020-2025) & (US$ Million)

Table 47. Stryker Corporation Recent Development

Table 48. Johnson & Johnson Company Details

Table 49. Johnson & Johnson Business Overview

Table 50. Johnson & Johnson Neurovascular Devices Product

Table 51. Johnson & Johnson Revenue in Neurovascular Devices Business (2020-2025) & (US$ Million)

Table 52. Johnson & Johnson Recent Development

Table 53. Medtronic Company Details

Table 54. Medtronic Business Overview

Table 55. Medtronic Neurovascular Devices Product

Table 56. Medtronic Revenue in Neurovascular Devices Business (2020-2025) & (US$ Million)

Table 57. Medtronic Recent Development

Table 58. Terumo Neuro Company Details

Table 59. Terumo Neuro Business Overview

Table 60. Terumo Neuro Neurovascular Devices Product

Table 61. Terumo Neuro Revenue in Neurovascular Devices Business (2020-2025) & (US$ Million)

Table 62. Terumo Neuro Recent Development

Table 63. Penumbra, Inc. (Neuro) Company Details

Table 64. Penumbra, Inc. (Neuro) Business Overview

Table 65. Penumbra, Inc. (Neuro) Neurovascular Devices Product

Table 66. Penumbra, Inc. (Neuro) Revenue in Neurovascular Devices Business (2020-2025) & (US$ Million)

Table 67. Penumbra, Inc. (Neuro) Recent Development

Table 68. Shanghai MicroPort Medical (Group) Co.，Ltd. Company Details

Table 69. Shanghai MicroPort Medical (Group) Co.，Ltd. Business Overview

Table 70. Shanghai MicroPort Medical (Group) Co.，Ltd. Neurovascular Devices Product

Table 71. Shanghai MicroPort Medical (Group) Co.，Ltd. Revenue in Neurovascular Devices Business (2020-2025) & (US$ Million)

Table 72. Shanghai MicroPort Medical (Group) Co.，Ltd. Recent Development

Table 73. Abbott Vascular Company Details

Table 74. Abbott Vascular Business Overview

Table 75. Abbott Vascular Neurovascular Devices Product

Table 76. Abbott Vascular Revenue in Neurovascular Devices Business (2020-2025) & (US$ Million)

Table 77. Abbott Vascular Recent Development

Table 78. Medical Murray Company Details

Table 79. Medical Murray Business Overview

Table 80. Medical Murray Neurovascular Devices Product

Table 81. Medical Murray Revenue in Neurovascular Devices Business (2020-2025) & (US$ Million)

Table 82. Medical Murray Recent Development

Table 83. Boston Scientific Company Details

Table 84. Boston Scientific Business Overview

Table 85. Boston Scientific Neurovascular Devices Product

Table 86. Boston Scientific Revenue in Neurovascular Devices Business (2020-2025) & (US$ Million)

Table 87. Boston Scientific Recent Development

Table 88. Neurovascular Devices Market Trends

Table 89. Neurovascular Devices Market Drivers

Table 90. Neurovascular Devices Market Challenges

Table 91. Neurovascular Devices Market Restraints

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

List of Figures

Figure 1. Neurovascular Devices Product Picture

Figure 2. Global Neurovascular Devices Market Share by Type: 2024 VS 2031

Figure 3. Thrombectomy Devices Features

Figure 4. Intracranial Stents Features

Figure 5. Embolization Devices Features

Figure 6. Flow Diversion Devices Features

Figure 7. Others Features

Figure 8. Global Neurovascular Devices Market Share by Application: 2024 VS 2031

Figure 9. Stroke Treatment

Figure 10. Aneurysm Treatment

Figure 11. Cerebral Vascular Stenosis Treatment

Figure 12. Traumatic Brain Injury and Intracranial Hemorrhage Treatment

Figure 13. Others

Figure 14. Neurovascular Devices Report Years Considered

Figure 15. Global Neurovascular Devices Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Neurovascular Devices Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Neurovascular Devices Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Neurovascular Devices Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Europe Neurovascular Devices Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. China Neurovascular Devices Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Japan Neurovascular Devices Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Global Neurovascular Devices Market Share by Players in 2024

Figure 23. Global Top Neurovascular Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Devices as of 2024)

Figure 24. The Top 10 and 5 Players Market Share by Neurovascular Devices Revenue in 2024

Figure 25. North America Neurovascular Devices Market Share by Type (2020-2025)

Figure 26. North America Neurovascular Devices Market Share by Application (2020-2025)

Figure 27. Europe Neurovascular Devices Market Share by Type (2020-2025)

Figure 28. Europe Neurovascular Devices Market Share by Application (2020-2025)

Figure 29. China Neurovascular Devices Market Share by Type (2020-2025)

Figure 30. China Neurovascular Devices Market Share by Application (2020-2025)

Figure 31. Japan Neurovascular Devices Market Share by Type (2020-2025)

Figure 32. Japan Neurovascular Devices Market Share by Application (2020-2025)

Figure 33. Stryker Corporation Revenue Growth Rate in Neurovascular Devices Business (2020-2025)

Figure 34. Johnson & Johnson Revenue Growth Rate in Neurovascular Devices Business (2020-2025)

Figure 35. Medtronic Revenue Growth Rate in Neurovascular Devices Business (2020-2025)

Figure 36. Terumo Neuro Revenue Growth Rate in Neurovascular Devices Business (2020-2025)

Figure 37. Penumbra, Inc. (Neuro) Revenue Growth Rate in Neurovascular Devices Business (2020-2025)

Figure 38. Shanghai MicroPort Medical (Group) Co.，Ltd. Revenue Growth Rate in Neurovascular Devices Business (2020-2025)

Figure 39. Abbott Vascular Revenue Growth Rate in Neurovascular Devices Business (2020-2025)

Figure 40. Medical Murray Revenue Growth Rate in Neurovascular Devices Business (2020-2025)

Figure 41. Boston Scientific Revenue Growth Rate in Neurovascular Devices Business (2020-2025)

Figure 42. Bottom-up and Top-down Approaches for This Report

Figure 43. Data Triangulation

Figure 44. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Neurovascular Devices market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Neurovascular Devices market is 5.3% 2025 to 2031.

Which companies rank high in the global Neurovascular Devices market? shouQi

What was the global market size of Neurovascular Devices in 2031? shouQi

What was the global market size of Neurovascular Devices in 2025? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Neurovascular Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurovascular Devices market size was US$ 3216 million in 2025 and is forecast to reach a readjusted size of US$ 4593 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 76
USD 4250.00
(Single User License)
Global Neurovascular Devices Market Research Report 2026
The global Neurovascular Devices market was valued at US$ 3216 million in 2025 and is anticipated to reach US$ 4593 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 106
USD 2900.00
(Single User License)
Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurovascular Devices was estimated to be worth US$ 3216 million in 2025 and is projected to reach US$ 4593 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 95
USD 3950.00
(Single User License)
Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Devices was estimated to be worth US$ 3195 million in 2024 and is forecast to a readjusted size of US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-11-05
Pages: 94
USD 3950.00
(Single User License)
Global Neurovascular Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neurovascular Devices market is projected to grow from US$ 3195 million in 2024 to US$ 4384 million by 2031, at a CAGR of 5.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 127
USD 4900.00
(Single User License)
Global Neurovascular Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Neurovascular Devices was estimated to be worth US$ 3195 million and is forecast to reach approximately US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 125
USD 5900.00
(Single User License)
Global Neurovascular Devices Market Insights, Forecast to 2031
Valued at US$ 3216 million in 2024, the global Neurovascular Devices market is forecast to reach US$ 4384 million by 2030, at a CAGR of 5.3% during the forecast period.
Published Date: 2025-02-14
Pages: 123
USD 4900.00
(Single User License)
Global Neurovascular Devices Market Research Report 2025
The global market for Neurovascular Devices was valued at US$ 3195 million in the year 2024 and is projected to reach a revised size of US$ 4384 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published Date: 2025-02-14
Pages: 80
USD 2900.00
(Single User License)
Neurovascular Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Devices was estimated to be worth US$ 205 million in 2024 and is forecast to a readjusted size of US$ 297 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 109
USD 3950.00
(Single User License)
Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Published Date: 2024-01-06
Pages: 98
USD 3950.00
(Single User License)

Global Neurovascular Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurovascular Devices market size was US$ 3216 million in 2025 and is forecast to reach a readjusted size of US$ 4593 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 76
USD 4250.00 (Single User License)
Global Neurovascular Devices Market Research Report 2026
The global Neurovascular Devices market was valued at US$ 3216 million in 2025 and is anticipated to reach US$ 4593 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 106
USD 2900.00 (Single User License)
Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurovascular Devices was estimated to be worth US$ 3216 million in 2025 and is projected to reach US$ 4593 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 95
USD 3950.00 (Single User License)
Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Devices was estimated to be worth US$ 3195 million in 2024 and is forecast to a readjusted size of US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-11-05
Pages: 94
USD 3950.00 (Single User License)
Global Neurovascular Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neurovascular Devices market is projected to grow from US$ 3195 million in 2024 to US$ 4384 million by 2031, at a CAGR of 5.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 127
USD 4900.00 (Single User License)
Global Neurovascular Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Neurovascular Devices was estimated to be worth US$ 3195 million and is forecast to reach approximately US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 125
USD 5900.00 (Single User License)
Global Neurovascular Devices Market Insights, Forecast to 2031
Valued at US$ 3216 million in 2024, the global Neurovascular Devices market is forecast to reach US$ 4384 million by 2030, at a CAGR of 5.3% during the forecast period.
Published: 2025-02-14
Pages: 123
USD 4900.00 (Single User License)
Global Neurovascular Devices Market Research Report 2025
The global market for Neurovascular Devices was valued at US$ 3195 million in the year 2024 and is projected to reach a revised size of US$ 4384 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published: 2025-02-14
Pages: 80
USD 2900.00 (Single User License)
Neurovascular Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Devices was estimated to be worth US$ 205 million in 2024 and is forecast to a readjusted size of US$ 297 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 109
USD 3950.00 (Single User License)
Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Published: 2024-01-06
Pages: 98
USD 3950.00 (Single User License)